Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 16 to 20, 2020. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 16 to 20, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
FDA Issues EUA to Baricitinib Plus Remdesivir for COVID-19
FRIDAY, Nov. 20, 2020 (HealthDay News) — Emergency use authorization was issued for baricitinib in combination with remdesivir for hospitalized patients with COVID-19, the U.S. Food and Drug Administration announced Thursday.
High-Dose Anticoagulation May Not Aid COVID-19 Patients
FRIDAY, Nov. 20, 2020 (HealthDay News) — Higher doses of blood thinners are potentially harmful and have no clear benefits for hospitalized COVID-19 patients, according to a study published online Nov. 5 in Thrombosis Research.
Behavioral, Psych Condition Care Shifted to Telemedicine During COVID-19
FRIDAY, Nov. 20, 2020 (HealthDay News) — Office-based visits for behavioral and psychiatric conditions decreased in association with the COVID-19 pandemic, although increases in telemedicine visits offset these decreases, according to a research letter published online Nov. 17 in the Annals of Internal Medicine.
Predictors of Severe Disease ID’d in Children With SARS-CoV-2
THURSDAY, Nov. 19, 2020 (HealthDay News) — Predictors of severe disease have been identified for children with severe acute respiratory syndrome coronavirus 2, according to a study published online Nov. 13 in The Journal of Pediatrics.
COVID-19-Related Job Insecurity Tied to Anxiety, Depression
THURSDAY, Nov. 19, 2020 (HealthDay News) — Job insecurity as a result of the COVID-19 pandemic is associated with self-reported anxiety and depression among U.S. young adults, according to a study published online Nov. 9 in the Journal of Adolescent Health.
U.S. COVID-19 Deaths Top a Quarter Million
THURSDAY, Nov. 19, 2020 (HealthDay News) — The United States crossed a grim threshold on Wednesday: More than 250,000 Americans have now died from COVID-19.
Pandemic Affecting Young People’s Mental Health
WEDNESDAY, Nov. 18, 2020 (HealthDay News) — Nearly half of U.S. young adults report symptoms of depression, with more than one-third reporting thoughts of death or suicide, according to the results of a survey released by the COVID-19 Consortium for Understanding the Public’s Policy Preferences Across States.
Fluvoxamine Linked to Reduction in Clinical Deterioration in COVID-19
WEDNESDAY, Nov. 18, 2020 (HealthDay News) — For adult outpatients with COVID-19, fluvoxamine is associated with a reduction in clinical deterioration, according to a study published online Nov. 12 in the Journal of the American Medical Association.
AAP Urges Inclusion of Children in SARS-CoV-2 Vaccine Trials
Significant Association ID"d Between Hepatitis C, Overactive Bladder .jpg)
Study Looks at Barriers to Initiation of Rotavirus Vaccine 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Obstructive Sleep Apnea Tied to Nearly Doubled Risk for Flu, COVID-19 in Childhood 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Physical Exams May Not Reliably Diagnose Pediatric Pneumonia .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
